Product Information
MATZIM LA 180 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.9582 per EA under NDC 52544069130. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 15, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
52544069130
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077686FDA Approved
3/15/2010
TE Code
AB
On Market Since
3/28/2011
Pharmacological Classes
Price Statistics
The NADAC for MATZIM LA 180 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9582 per EA |
|---|---|
| All-time high | $2.3015 (Oct 15, 2014) |
| All-time low | $0.9582 (Aug 19, 2026) |
| 52-week high | $1.6318 |
| 52-week low | $0.9582 |
| Median price | $2.0953 |
| Average price | $1.9715 |
| Largest weekly change | +47.4% (Aug 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MATZIM LA 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MATZIM LA 180 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.9582 per EA (NDC 52544069130), effective Aug 19, 2026.
How has the price of MATZIM LA 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for MATZIM LA 180 MG TABLET has declined 57.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MATZIM LA 180 MG TABLET?
Since Nov 28, 2013, the NADAC for MATZIM LA 180 MG TABLET has ranged from a low of $0.9582 (Aug 19, 2026) to a high of $2.3015 (Oct 15, 2014), with a median of $2.0953 per EA.
Are there cheaper alternatives to MATZIM LA 180 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MATZIM LA 180 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MATZIM LA 180 MG TABLET?
MATZIM LA 180 MG TABLET (NDC 52544069130) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.